Profile | GDS2987 / GI_6806896-I |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 117.5 | 78 |
GSM215244 | HMVEC_vehicle_rep2 | 144.4 | 79 |
GSM215253 | HMVEC_vehicle_rep3 | 159.7 | 81 |
GSM215254 | HMVEC_atorvastatin_rep1 | 178.6 | 81 |
GSM215282 | HMVEC_atorvastatin_rep3 | 209.9 | 82 |
GSM215344 | HMVEC_atorvastatin_rep2 | 230.7 | 83 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 173.5 | 81 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 154.3 | 79 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 135.1 | 78 |
GSM215294 | HMVEC_SLx2119_rep1 | 118.2 | 78 |
GSM215295 | HMVEC_SLx2119_rep2 | 92.4 | 74 |
GSM215296 | HMVEC_SLx2119_rep3 | 81.6 | 72 |
GSM215297 | PASMC_vehicle_rep1 | 7.4 | 12 |
GSM215298 | PASMC_vehicle_rep2 | ||
GSM215310 | PASMC_vehicle_rep3 | ||
GSM215311 | PASMC_atorvastatin_rep1 | ||
GSM215312 | PASMC_atorvastatin_rep2 | ||
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | ||
GSM215330 | Fibroblasts_vehicle_rep1 | 31.8 | 56 |
GSM215331 | Fibroblasts_vehicle_rep2 | 28.5 | 58 |
GSM215332 | Fibroblasts_vehicle_rep3 | 32.8 | 64 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 48.2 | 68 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 42.9 | 66 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 30.1 | 56 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 44.4 | 68 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 27.4 | 61 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 48.3 | 68 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 33.6 | 63 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 40.4 | 66 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 39.3 | 64 |